江苏吴中医药集团有限公司苏州制药厂
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
290
NMPA:290
Drug Approvals
lansoprazole for Injection
- Product Name
- 注射用兰索拉唑
- Approval Number
- 国药准字H20140044
- Approval Date
- Mar 8, 2024
NMPA
Gabexate Mesilate for Injection
- Product Name
- 注射用甲磺酸加贝酯
- Approval Number
- 国药准字H20093471
- Approval Date
- Mar 8, 2024
NMPA
Dobutamine Hydrochloride Injection
- Product Name
- 盐酸多巴酚丁胺注射液
- Approval Number
- 国药准字H20247037
- Approval Date
- Mar 1, 2024
NMPA
Linezolid and Sodium Chloride Injection
- Product Name
- 利奈唑胺氯化钠注射液
- Approval Number
- 国药准字H20234142
- Approval Date
- Sep 12, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 29
- Next
Clinical Trials
No trials found
News
No news found